Gene · 9572
Papers2,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive integrative analysis of circadian rhythms in human saliva. | NPJ Biol Timing Sleep | 2025 | 41776245 | PubTator, text mining | PubMed |
| Personalized chronotherapy in glioblastoma: integrating circadian profiling and PK-PD modelling to optimize temozolomide timing. | NPJ Precis Oncol | 2025 | 41387951 | PubTator, text mining | PubMed |
| Weight loss increases circadian gene expression and emotional well-being in individuals with obesity. | Front Nutr | 2025 | 41383341 | PubTator, text mining | PubMed |
| Comprehensive and In-Depth Molecular and Pathway Studies of the Hippocampus in Alzheimer's Disease. | Cell Mol Neurobiol | 2025 | 41317176 | PubTator, text mining | PubMed |
| Nr1d1 Regulates Microglia M1/M2 Polarization to Alleviate Neuroinflammation after Traumatic Brain Injury. | ACS Chem Neurosci | 2025 | 41296614 | PubTator, text mining | PubMed |
| Type 2 Diabetes and Obesity Alter Exercise Training-Induced Transcriptional Adaptations to Subcutaneous White Adipose Tissue. | bioRxiv | 2025 | 41279622 | PubTator, text mining | PubMed |
| Vasostatin-2 attenuates injury-induced neointimal hyperplasia through the ACE2/MasR/PPARγ/NR1D1/Gas1 axis. | Cardiovasc Res | 2025 | 41231769 | PubTator, text mining | PubMed |
| Circadian rhythm in mycotoxin-induced immunotoxicity: an emerging regulatory axis? | Front Pharmacol | 2025 | 41208874 | PubTator, text mining | PubMed |
| TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1. | Cell Oncol (Dordr) | 2025 | 41171371 | PubTator, text mining | PubMed |
| Design, multicomponent synthesis, and molecular modelling studies of tetrazole biphenyls as REV-ERBα modulators. | Bioorg Chem | 2025 | 41167054 | PubTator, text mining | PubMed |
| Uncovering Anticancer Mechanisms of Spiramycin Derivatives Using Transcriptomic and Metabolomic Analyses. | Metabolites | 2025 | 41149625 | PubTator, text mining | PubMed |
| Novel MAML2 Fusions in Human Malignancy. | Cancers (Basel) | 2025 | 41097675 | PubTator, text mining | PubMed |
| Precision Target Discovery for Migraine: An Integrated GWAS-eQTL-PheWAS Pipeline. | Molecules | 2025 | 41097341 | PubTator, text mining | PubMed |
| DeepEPI: CNN-transformer-based model for extracting TF interactions through predicting enhancer-promoter interactions. | Bioinform Adv | 2025 | 41031058 | PubTator, text mining | PubMed |
| Trisomy 21 Disrupts Thyroid Hormones Signaling During Human iPSC-Derived Neural Differentiation In Vitro. | Cells | 2025 | 41002374 | PubTator, text mining | PubMed |
| Toluquinol modulates NR1D1 and circadian rhythm in lung cancer cells: Implications for circadian medicine. | Chronobiol Int | 2025 | 40928115 | PubTator, text mining | PubMed |
| Role of NR1D1 in Colorectal Cancer: Impact on Prognosis, Immune Microenvironment, and Oncogenic Pathways. | Clin Lab | 2025 | 40923750 | PubTator, text mining | PubMed |
| NUTM2A-AS1 as a potential key regulator in cancer: unraveling its ceRNA networks and impact on tumor biology. | Eur J Med Res | 2025 | 40903777 | PubTator, text mining | PubMed |
| Targeting RBM10-Repressed RORB Activity in Liquid Condensates Inhibits Lysosomal Biogenesis and Neuroblastoma Progression via Affecting NF-κB Signaling. | Adv Sci (Weinh) | 2025 | 40899609 | PubTator, text mining | PubMed |
| Circadian rhythms in pediatric high-grade gliomas may contribute to treatment efficacy. | Sci Rep | 2025 | 40887493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9572/papers?page=3